Literature DB >> 2632259

Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture.

C S Murphy1, L F Meisner, S Q Wu, V C Jordan.   

Abstract

The effects of short- and long-term estrogen deprivation on T47D human breast cancer cells was studied. Cells were routinely grown in an estrogenized environment in media containing fetal bovine serum with phenol red indicator. Cells were estrogen deprived (grown in media containing dextran-coated charcoal-stripped fetal bovine serum without phenol red) for either 10 days or at least 8 months, and effects on genotype, receptor content, and cell growth responsiveness were studied. Cells grown in an estrogenized environment are hypertetraploid, whereas long-term estrogen-deprived cells have become hyperdiploid. Short-term estrogen-deprived cells exhibit a decreased growth rate and progesterone receptor (PgR) content, while estrogen receptor (ER) content is not significantly altered. ER mRNA levels are significantly decreased in these cells. Incubation of these cells with estradiol (10(-10) M) for 6 days causes a 5-fold stimulation in cell growth and this stimulation can be inhibited by the antiestrogens 4-hydroxytamoxifen (4-OHT), ICI 164,384, and RU 39411. Cells cultured under long-term estrogen deprivation exhibited an increased growth rate and were refractory to the effects of estradiol and of 4-OHT on cell growth. These cells were ER negative with low levels of PgR; however, one clone of this line was found to be ER and PgR negative. No mRNA for the ER was detected in this line or its clone. With these cell lines it is possible to study the biological characteristics necessary for the outgrowth of a receptor negative, hormone nonresponsive cell population from a receptor positive, hormone-responsive population grown in a estrogen-free environment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2632259     DOI: 10.1016/0277-5379(89)90348-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  17 in total

1.  Regulation of the membrane estrogen receptor-alpha: role of cell density, serum, cell passage number, and estradiol.

Authors:  Celeste H Campbell; Nataliya Bulayeva; David B Brown; Bahiru Gametchu; Cheryl S Watson
Journal:  FASEB J       Date:  2002-12       Impact factor: 5.191

Review 2.  The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-10-22       Impact factor: 5.678

3.  MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.

Authors:  Gang Li; Mei Yang; Li Zuo; Mei-Xing Wang
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

4.  Development and characterization of breast carcinoma cell lines as in vitro and in vivo models for breast cancer diagnosis and therapy.

Authors:  R L Ceriani; J A Peterson; E W Blank; C M Chan; R Cailleau
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

Review 5.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

Review 6.  Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors:  V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal:  Breast       Date:  2007-08-24       Impact factor: 4.380

7.  Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.

Authors:  Ines Barone; Yukun Cui; Matthew H Herynk; Arnoldo Corona-Rodriguez; Cinzia Giordano; Jennifer Selever; Amanda Beyer; Sebastiano Andò; Suzanne A W Fuqua
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

8.  Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.

Authors:  Raymond Lo; Lyle Burgoon; Laura Macpherson; Shaimaa Ahmed; Jason Matthews
Journal:  Biochim Biophys Acta       Date:  2010-01-14

9.  Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.

Authors:  W V Welshons; L H Grady; K S Engler; B M Judy
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.

Authors:  Elizabeth E Sweeney; Russell E McDaniel; Philipp Y Maximov; Ping Fan; V Craig Jordan
Journal:  Horm Mol Biol Clin Investig       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.